Author

S. Nisole

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:human· 4 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

G. Maarifi· 3 shared A. Baidaliuk· 1 shared A. Baudry· 1 shared A. Hardy· 1 shared A. L. Chaves Valadao· 1 shared A. Llibre· 1 shared A. Mac Kain· 1 shared A. Rebendenne· 1 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

G. Maarifi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Targeting the chemokine receptor CXCR4 with histamine analogue to reduce inflammation in juvenile arthritis: a proof of concept for COVID-19 therapeutic approach

N. Bekaddour, N. Smith, B. Beitz, A. Llibre, T. Dott, A. Baudry, A.-S. Korganow, S. Nisole, R. Mouy, S. Breton, B. Bader-Meunier, D. Duffy, B. Terrier, B. Schneider, P. Quartier, , J.-P. Herbeuval

This study shows that targeting CXCR4 with clobenpropit reduces inflammation in juvenile arthritis and COVID-19 by lowering cytokine levels and immune cell activity.

bioRxiv · Oct 24, 2021 · PreprintImmunology

Usutu virus escapes langerin-induced restriction to productively infect human Langerhans cells, unlike West Nile virus.

M.-F. Martin, G. Maarifi, H. Abiven, M. Seffals, N. Mouchet, C. Beck, C. Bodet, N. Leveque, N. J. Arhel, F. P. Blanchet, Y. Simonin, S. Nisole

This study shows that Usutu virus (USUV) uses langerin to infect human Langerhans cells more efficiently than West Nile virus (WNV), which is restricted by langerin.

bioRxiv · Aug 17, 2021Microbiology

Identification of DAXX As A Restriction Factor Of SARS-CoV-2 Through A CRISPR/Cas9 Screen

A. Mac Kain, G. Maarifi, S.-M. Aicher, N. Arhel, A. Baidaliuk, S. Munier, F. Donati, T. Vallet, Q. D. Tran, A. Hardy, M. Chazal, F. Porrot, M. Ohainle, J. Carlson-Stevermer, J. Oki, , F. Roesch

The paper identifies DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen, showing it limits viral replication independently of SUMOylation.

bioRxiv · May 6, 2021Microbiology

SARS-CoV-2 replication triggers an MDA-5-dependent interferon production which is unable to efficiently control replication

A. Rebendenne, A. L. Chaves Valadao, M. Tauziet, G. Maarifi, B. Bonaventure, R. Planes, J. McKellar, S. Nisole, M. Arnaud-Arnould, O. Moncorge, C. Goujon

This study shows that SARS-CoV-2 triggers MDA-5-dependent interferon production in human cells, but this response fails to control viral replication.

bioRxiv · Oct 28, 2020Microbiology